AE-ITU (dihydrobromide)

AE-ITU dihydrobromide is the dihydrobromide form of AE-ITU. AE-ITU dihydrobromide is a selective inhibitor for inducible NO synthase (iNOS), and attenuates the liver dysfunction caused by endotoxaemia in rats[1].

Product Specifications

CAS Number

[56-10-0]

UNSPSC

12352211

Hazard Statement

H302, H315, H319, H335

Target

NO Synthase

Type

Reference compound

Related Pathways

Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/ae-itu-dihydrobromide.html

Purity

98.0

Solubility

H2O : ≥ 100 mg/mL

Smiles

NC(SCCN)=N.[H]Br.[H]Br

Molecular Formula

C3H11Br2N3S

Molecular Weight

281.01

Precautions

H302, H315, H319, H335

References & Citations

[1]Thiemermann C, et al., The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol. 1995 Dec;116 (7) :2845-51.